These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 2230122

  • 41. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [Abstract] [Full Text] [Related]

  • 42. The role of the C9b domain in the binding of C9 molecules to EAC1-8 defined by monoclonal antibodies to C9.
    Yoden A, Moriyama T, Inoue K, Inai S.
    J Immunol; 1988 Apr 01; 140(7):2317-21. PubMed ID: 3351301
    [Abstract] [Full Text] [Related]

  • 43. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
    Joiner KA, Schmetz MA, Goldman RC, Leive L, Frank MM.
    Infect Immun; 1984 Jul 01; 45(1):113-7. PubMed ID: 6203836
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.
    Martin DE, Chiu FJ, Gigli I, Müller-Eberhard HJ.
    J Clin Invest; 1987 Jul 01; 80(1):226-33. PubMed ID: 3597774
    [Abstract] [Full Text] [Related]

  • 47. Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9.
    Papadimitriou JC, Ramm LE, Drachenberg CB, Trump BF, Shin ML.
    J Immunol; 1991 Jul 01; 147(1):212-7. PubMed ID: 1904901
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL, Kolb WP, Sodetz JM.
    J Immunol; 1987 Sep 15; 139(6):1960-4. PubMed ID: 3624872
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Arachidonic acid mobilization and phosphoinositide turnover by the terminal complement complex, C5b-9, in rat oligodendrocyte x C6 glioma cell hybrids.
    Shirazi Y, McMorris FA, Shin ML.
    J Immunol; 1989 Jun 15; 142(12):4385-91. PubMed ID: 2542410
    [Abstract] [Full Text] [Related]

  • 52. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization.
    McDonald JF, Nelsestuen GL.
    Biochemistry; 1997 Jun 17; 36(24):7464-73. PubMed ID: 9200695
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L, Morris CA, Sheehan MC, Charlesworth JA, Pussell BA.
    Clin Exp Immunol; 1993 Apr 17; 92(1):114-9. PubMed ID: 7682159
    [Abstract] [Full Text] [Related]

  • 57. Molecular composition of the terminal membrane and fluid-phase C5b-9 complexes of rabbit complement. Absence of disulphide-bonded C9 dimers in the membrane complex.
    Bhakdi S, Tranum-Jensen J.
    Biochem J; 1983 Mar 01; 209(3):753-61. PubMed ID: 6870789
    [Abstract] [Full Text] [Related]

  • 58. Ultrastructure of the membrane attack complex of complement: detection of the tetramolecular C9-polymerizing complex C5b-8.
    Tschopp J, Podack ER, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1982 Dec 01; 79(23):7474-8. PubMed ID: 6961424
    [Abstract] [Full Text] [Related]

  • 59. Fluid-phase assembly of the membrane attack complex of complement.
    Silversmith RE, Nelsestuen GL.
    Biochemistry; 1986 Feb 25; 25(4):841-51. PubMed ID: 3964648
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.